Not recruitingISRCTN11135486

Quetiapine versus sertraline as the pharmacological component in a standardised psychopharmacological and psychotherapeutic treatment of borderline personality disorder: a randomised, rater-blinded study

Interventional studyAges 18+GermanyPersonality disorders

The study in practice

Understand this study

Listed age limits: from 18 years.

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateNot clearly listed

Recruitment status: Not recruiting
Enrollment listed in the registry: Not clearly listed
Sponsor: University of Duesseldorf (Germany)
Sponsor type: University
Study type: Other
Intervention type: Other / unclear
Study phase: Not Specified
Locations: Germany
Age range: Over 18 Years
Official registry ID: ISRCTN11135486
Official title: Show the full official title
Quetiapine versus sertraline as the pharmacological component in a standardised psychopharmacological and psychotherapeutic treatment of borderline personality disorder: a randomised, rater-blinded study

Leave your email and we’ll get in touch to discuss your questions and possible next steps.

Not recruiting

Germany

Registry details

Registry conditions (original wording)

Borderline Personality Disorder; Mental and Behavioural Disorders

A listed location does not confirm current availability.

FAQ

Who is behind this study?

The study sponsor is University of Duesseldorf (Germany), a university.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as not recruiting.

Explore other studies

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.